nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Vismodegib—skin cancer	0.341	0.466	CbGbCtD
Gadobenate Dimeglumine—ALB—Vemurafenib—skin cancer	0.27	0.368	CbGbCtD
Gadobenate Dimeglumine—ALB—Fluorouracil—skin cancer	0.121	0.166	CbGbCtD
Gadobenate Dimeglumine—Dermatitis bullous—Docetaxel—skin cancer	0.00038	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Fluorouracil—skin cancer	0.000377	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Fluorouracil—skin cancer	0.000377	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vemurafenib—skin cancer	0.000377	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Temozolomide—skin cancer	0.000376	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Chills—Dactinomycin—skin cancer	0.000375	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Temozolomide—skin cancer	0.000373	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Temozolomide—skin cancer	0.000372	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Docetaxel—skin cancer	0.000372	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Vemurafenib—skin cancer	0.000372	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Temozolomide—skin cancer	0.000371	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Temozolomide—skin cancer	0.000371	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Imiquimod—skin cancer	0.000369	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Imiquimod—skin cancer	0.000366	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Docetaxel—skin cancer	0.000365	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Temozolomide—skin cancer	0.000364	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Dactinomycin—skin cancer	0.000364	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Docetaxel—skin cancer	0.000363	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Bleomycin—skin cancer	0.000362	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Bleomycin—skin cancer	0.000361	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vemurafenib—skin cancer	0.00036	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Docetaxel—skin cancer	0.000358	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Imiquimod—skin cancer	0.000356	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Imiquimod—skin cancer	0.000354	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Imiquimod—skin cancer	0.000354	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Temozolomide—skin cancer	0.000353	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Temozolomide—skin cancer	0.000352	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Bleomycin—skin cancer	0.000352	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Temozolomide—skin cancer	0.000351	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Temozolomide—skin cancer	0.000351	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Bleomycin—skin cancer	0.000349	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Fluorouracil—skin cancer	0.000349	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vemurafenib—skin cancer	0.000347	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Fluorouracil—skin cancer	0.000347	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Temozolomide—skin cancer	0.000343	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Temozolomide—skin cancer	0.000341	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Temozolomide—skin cancer	0.000341	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Cough—Bleomycin—skin cancer	0.00034	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Chills—Temozolomide—skin cancer	0.000339	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Dactinomycin—skin cancer	0.000338	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Dactinomycin—skin cancer	0.000336	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Docetaxel—skin cancer	0.000335	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vemurafenib—skin cancer	0.000334	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Bleomycin—skin cancer	0.000332	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Bleomycin—skin cancer	0.000332	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vemurafenib—skin cancer	0.000331	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Temozolomide—skin cancer	0.000331	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vemurafenib—skin cancer	0.000331	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Imiquimod—skin cancer	0.00033	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vemurafenib—skin cancer	0.000329	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Temozolomide—skin cancer	0.000329	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Temozolomide—skin cancer	0.000329	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Bleomycin—skin cancer	0.000328	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Dactinomycin—skin cancer	0.000328	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000327	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Dactinomycin—skin cancer	0.000326	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Docetaxel—skin cancer	0.000325	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Temozolomide—skin cancer	0.000322	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Imiquimod—skin cancer	0.000322	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Bleomycin—skin cancer	0.000321	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00032	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Bleomycin—skin cancer	0.000318	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Temozolomide—skin cancer	0.000318	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Imiquimod—skin cancer	0.000317	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Infection—Bleomycin—skin cancer	0.000316	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vemurafenib—skin cancer	0.000312	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Fluorouracil—skin cancer	0.000311	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Dactinomycin—skin cancer	0.00031	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Bronchospasm—Docetaxel—skin cancer	0.000309	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Temozolomide—skin cancer	0.000308	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Imiquimod—skin cancer	0.000307	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Dactinomycin—skin cancer	0.000306	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Temozolomide—skin cancer	0.000305	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Temozolomide—skin cancer	0.000304	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Fluorouracil—skin cancer	0.000303	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Temozolomide—skin cancer	0.000301	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Bleomycin—skin cancer	0.000297	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Temozolomide—skin cancer	0.000297	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Imiquimod—skin cancer	0.000296	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Infection—Dactinomycin—skin cancer	0.000295	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Temozolomide—skin cancer	0.000295	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Temozolomide—skin cancer	0.000291	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00029	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Cough—Temozolomide—skin cancer	0.000287	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Bleomycin—skin cancer	0.000286	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Imiquimod—skin cancer	0.000285	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Temozolomide—skin cancer	0.000284	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Bleomycin—skin cancer	0.000284	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Rash—Imiquimod—skin cancer	0.000283	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Imiquimod—skin cancer	0.000282	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Headache—Imiquimod—skin cancer	0.000281	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Fluorouracil—skin cancer	0.00028	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Temozolomide—skin cancer	0.00028	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Temozolomide—skin cancer	0.00028	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Docetaxel—skin cancer	0.00028	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Docetaxel—skin cancer	0.00028	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Temozolomide—skin cancer	0.000279	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000278	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Temozolomide—skin cancer	0.000277	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Docetaxel—skin cancer	0.000275	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Temozolomide—skin cancer	0.000274	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Pain—Bleomycin—skin cancer	0.000272	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Docetaxel—skin cancer	0.000272	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Fluorouracil—skin cancer	0.000271	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Temozolomide—skin cancer	0.000271	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000271	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Temozolomide—skin cancer	0.000269	0.001	CcSEcCtD
Gadobenate Dimeglumine—Infection—Temozolomide—skin cancer	0.000267	0.000998	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Imiquimod—skin cancer	0.000266	0.000996	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Temozolomide—skin cancer	0.000263	0.000985	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Bleomycin—skin cancer	0.000262	0.000982	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Temozolomide—skin cancer	0.000261	0.000976	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Temozolomide—skin cancer	0.00026	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Fluorouracil—skin cancer	0.000258	0.000966	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Fluorouracil—skin cancer	0.000258	0.000966	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Dactinomycin—skin cancer	0.000256	0.000958	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Fluorouracil—skin cancer	0.000255	0.000954	CcSEcCtD
Gadobenate Dimeglumine—Pain—Dactinomycin—skin cancer	0.000254	0.00095	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Bleomycin—skin cancer	0.000253	0.000946	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Docetaxel—skin cancer	0.000252	0.000943	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Bleomycin—skin cancer	0.000252	0.000942	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Docetaxel—skin cancer	0.00025	0.000936	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Fluorouracil—skin cancer	0.000249	0.000933	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Docetaxel—skin cancer	0.000248	0.000929	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Docetaxel—skin cancer	0.000248	0.000926	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Fluorouracil—skin cancer	0.000247	0.000926	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Docetaxel—skin cancer	0.000247	0.000924	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Docetaxel—skin cancer	0.000246	0.000922	CcSEcCtD
Gadobenate Dimeglumine—Infection—Fluorouracil—skin cancer	0.000246	0.00092	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Dactinomycin—skin cancer	0.000245	0.000915	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000245	0.000915	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000243	0.000908	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Fluorouracil—skin cancer	0.000243	0.000908	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Docetaxel—skin cancer	0.000242	0.000906	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Fluorouracil—skin cancer	0.000241	0.000903	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Temozolomide—skin cancer	0.000241	0.000902	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Temozolomide—skin cancer	0.000239	0.000896	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Temozolomide—skin cancer	0.000239	0.000893	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Temozolomide—skin cancer	0.000236	0.000884	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Docetaxel—skin cancer	0.000235	0.000879	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Dactinomycin—skin cancer	0.000235	0.000878	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Dactinomycin—skin cancer	0.000235	0.000878	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Bleomycin—skin cancer	0.000235	0.000878	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Docetaxel—skin cancer	0.000233	0.000873	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Docetaxel—skin cancer	0.000233	0.000873	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000232	0.000867	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Temozolomide—skin cancer	0.000232	0.000866	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Fluorouracil—skin cancer	0.000231	0.000865	CcSEcCtD
Gadobenate Dimeglumine—Pain—Temozolomide—skin cancer	0.00023	0.000859	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Temozolomide—skin cancer	0.00023	0.000859	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Bleomycin—skin cancer	0.000228	0.000855	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Docetaxel—skin cancer	0.000228	0.000853	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Docetaxel—skin cancer	0.000227	0.000849	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Docetaxel—skin cancer	0.000227	0.000848	CcSEcCtD
Gadobenate Dimeglumine—Chills—Docetaxel—skin cancer	0.000226	0.000844	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000225	0.000843	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Bleomycin—skin cancer	0.000225	0.000843	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Docetaxel—skin cancer	0.000225	0.00084	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Fluorouracil—skin cancer	0.000222	0.000831	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Temozolomide—skin cancer	0.000221	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Fluorouracil—skin cancer	0.000221	0.000825	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Docetaxel—skin cancer	0.00022	0.000824	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Fluorouracil—skin cancer	0.00022	0.000823	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Temozolomide—skin cancer	0.00022	0.000822	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Docetaxel—skin cancer	0.000219	0.000819	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Docetaxel—skin cancer	0.000219	0.000819	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Dactinomycin—skin cancer	0.000219	0.000818	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Fluorouracil—skin cancer	0.000218	0.000815	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Docetaxel—skin cancer	0.000214	0.000802	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000214	0.000799	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Temozolomide—skin cancer	0.000213	0.000798	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dactinomycin—skin cancer	0.000213	0.000797	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Temozolomide—skin cancer	0.000212	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Temozolomide—skin cancer	0.000212	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Docetaxel—skin cancer	0.000212	0.000792	CcSEcCtD
Gadobenate Dimeglumine—Pain—Fluorouracil—skin cancer	0.000212	0.000792	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Docetaxel—skin cancer	0.00021	0.000787	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Fluorouracil—skin cancer	0.000204	0.000763	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dactinomycin—skin cancer	0.000203	0.00076	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Bleomycin—skin cancer	0.000202	0.000757	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Docetaxel—skin cancer	0.000202	0.000757	CcSEcCtD
Gadobenate Dimeglumine—Rash—Bleomycin—skin cancer	0.000201	0.000751	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Bleomycin—skin cancer	0.000201	0.00075	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Temozolomide—skin cancer	0.000198	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Fluorouracil—skin cancer	0.000197	0.000735	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Docetaxel—skin cancer	0.000196	0.000734	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Docetaxel—skin cancer	0.000196	0.000733	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Fluorouracil—skin cancer	0.000196	0.000732	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Docetaxel—skin cancer	0.000193	0.000723	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Temozolomide—skin cancer	0.000193	0.000721	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Docetaxel—skin cancer	0.000192	0.00072	CcSEcCtD
Gadobenate Dimeglumine—Cough—Docetaxel—skin cancer	0.000191	0.000714	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Temozolomide—skin cancer	0.00019	0.000711	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Bleomycin—skin cancer	0.000189	0.000707	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Docetaxel—skin cancer	0.000189	0.000707	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dactinomycin—skin cancer	0.000189	0.000706	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—skin cancer	0.000187	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Docetaxel—skin cancer	0.000186	0.000697	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Docetaxel—skin cancer	0.000186	0.000697	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Docetaxel—skin cancer	0.000186	0.000697	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000185	0.000692	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Temozolomide—skin cancer	0.000184	0.000687	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Fluorouracil—skin cancer	0.000182	0.000682	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Docetaxel—skin cancer	0.000182	0.000682	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Docetaxel—skin cancer	0.00018	0.000674	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Docetaxel—skin cancer	0.000179	0.000668	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Temozolomide—skin cancer	0.000178	0.000664	CcSEcCtD
Gadobenate Dimeglumine—Infection—Docetaxel—skin cancer	0.000177	0.000664	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—skin cancer	0.000176	0.00066	CcSEcCtD
Gadobenate Dimeglumine—Shock—Docetaxel—skin cancer	0.000176	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Docetaxel—skin cancer	0.000175	0.000655	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Fluorouracil—skin cancer	0.000175	0.000655	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Docetaxel—skin cancer	0.000174	0.000652	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Docetaxel—skin cancer	0.000173	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Temozolomide—skin cancer	0.000171	0.000639	CcSEcCtD
Gadobenate Dimeglumine—Rash—Temozolomide—skin cancer	0.000169	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Fluorouracil—skin cancer	0.000169	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Temozolomide—skin cancer	0.000169	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Headache—Temozolomide—skin cancer	0.000168	0.000629	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Docetaxel—skin cancer	0.000167	0.000624	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Fluorouracil—skin cancer	0.000164	0.000612	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000163	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Docetaxel—skin cancer	0.00016	0.0006	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Temozolomide—skin cancer	0.00016	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Docetaxel—skin cancer	0.000159	0.000596	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Docetaxel—skin cancer	0.000159	0.000594	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Fluorouracil—skin cancer	0.000157	0.000589	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Docetaxel—skin cancer	0.000157	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Rash—Fluorouracil—skin cancer	0.000156	0.000584	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Fluorouracil—skin cancer	0.000156	0.000583	CcSEcCtD
Gadobenate Dimeglumine—Headache—Fluorouracil—skin cancer	0.000155	0.00058	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000154	0.000577	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Docetaxel—skin cancer	0.000154	0.000576	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Docetaxel—skin cancer	0.000153	0.000571	CcSEcCtD
Gadobenate Dimeglumine—Pain—Docetaxel—skin cancer	0.000153	0.000571	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Docetaxel—skin cancer	0.000147	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fluorouracil—skin cancer	0.000147	0.00055	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Docetaxel—skin cancer	0.000146	0.000546	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Docetaxel—skin cancer	0.000141	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Docetaxel—skin cancer	0.000141	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Docetaxel—skin cancer	0.000132	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Docetaxel—skin cancer	0.000128	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Docetaxel—skin cancer	0.000126	0.000473	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Docetaxel—skin cancer	0.000122	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Docetaxel—skin cancer	0.000118	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Docetaxel—skin cancer	0.000114	0.000425	CcSEcCtD
Gadobenate Dimeglumine—Rash—Docetaxel—skin cancer	0.000113	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Docetaxel—skin cancer	0.000112	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Headache—Docetaxel—skin cancer	0.000112	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Docetaxel—skin cancer	0.000106	0.000397	CcSEcCtD
